TIME TO EXPAND THE USE OF CASIRIVIMAB/IMDEVIMAB MONOCLONAL ANTIBODY THERAPY? A CASE OF COMPASSIONATE USE IN SEVERE COVID-19 PNEUMONIA

Detalles Bibliográficos
Autores principales: AHMED, MUBASHIR AYAZ, HOSSAIN ESHAN, SHAYET, HUSSEIN, SAMI, SUN, CHENYU, SANKARAN RAJAGOPALAN, KAMALNATH, HUSSEIN, KHALID
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Chest Physicians. Published by Elsevier Inc. 2022
Materias:
Chest Infection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549007/
http://dx.doi.org/10.1016/j.chest.2022.08.262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549007/
http://dx.doi.org/10.1016/j.chest.2022.08.262

Ejemplares similares